AXLA
Price
$4.58
Change
-$0.00 (-0.00%)
Updated
Nov 22, 6:59 PM EST
MDGL
Price
$197.36
Change
+$6.42 (+3.36%)
Updated
Nov 29, 6:59 PM EST
84 days until earnings call
Ad is loading...

AXLA vs MDGL ᐉ Comparison: Which is Better to Invest?

Header iconAXLA vs MDGL Comparison
Open Charts AXLA vs MDGLBanner chart's image
Axcella Health
Price$4.58
Change-$0.00 (-0.00%)
Volume$25.01K
CapitalizationN/A
Madrigal Pharmaceuticals
Price$197.36
Change+$6.42 (+3.36%)
Volume$155.95K
CapitalizationN/A
View a ticker or compare two or three
AXLA vs MDGL Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AXLA vs. MDGL commentary
Nov 30, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXLA is a StrongSell and MDGL is a Buy.

COMPARISON
Comparison
Nov 30, 2023
Stock price -- (AXLA: $1.00 vs. MDGL: $197.36)
Brand notoriety: AXLA and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXLA: 42% vs. MDGL: 80%
Market capitalization -- AXLA: $16.86M vs. MDGL: $3.9B
AXLA [@Biotechnology] is valued at $16.86M. MDGL’s [@Biotechnology] market capitalization is $3.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXLA’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • AXLA’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both AXLA and MDGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXLA’s TA Score shows that 4 TA indicator(s) are bullish while MDGL’s TA Score has 6 bullish TA indicator(s).

  • AXLA’s TA Score: 4 bullish, 5 bearish.
  • MDGL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than AXLA.

Price Growth

AXLA (@Biotechnology) experienced а -78.19% price change this week, while MDGL (@Biotechnology) price change was +3.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.07%. For the same industry, the average monthly price growth was +33.96%, and the average quarterly price growth was +20.17%.

Reported Earning Dates

AXLA is expected to report earnings on Nov 15, 2023.

MDGL is expected to report earnings on Feb 22, 2024.

Industries' Descriptions

@Biotechnology (+1.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AXLA with price predictions.
OPEN
A.I.dvisor published
a Summary for MDGL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MDGL($3.9B) has a higher market cap than AXLA($16.9M). MDGL YTD gains are higher at: -32.003 vs. AXLA (-87.798). AXLA has higher annual earnings (EBITDA): -46.39M vs. MDGL (-336.4M). MDGL has more cash in the bank: 232M vs. AXLA (8.88M). AXLA has less debt than MDGL: AXLA (1.39M) vs MDGL (117M). AXLA (0) and MDGL (0) have equivalent revenues.
AXLAMDGLAXLA / MDGL
Capitalization16.9M3.9B0%
EBITDA-46.39M-336.4M14%
Gain YTD-87.798-32.003274%
P/E RatioN/AN/A-
Revenue00-
Total Cash8.88M232M4%
Total Debt1.39M117M1%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXLAMDGL
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 22 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SDVY29.270.29
+1.00%
First Trust SMID Cp Rising Div Achv ETF
SBI7.560.07
+0.95%
Western Asset Intermediate Muni Fund
HYGI25.520.11
+0.45%
iShares Inflation Hedged Hgh Yld Bd ETF
TYG27.910.12
+0.43%
Tortoise Energy Infrastructure Corp
OAEM28.52-0.19
-0.67%
OneAscent Emerging Markets ETF

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with VKTX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+3.36%
VKTX - MDGL
63%
Loosely correlated
+0.94%
SGMO - MDGL
62%
Loosely correlated
+4.98%
IBRX - MDGL
62%
Loosely correlated
-1.49%
KA - MDGL
62%
Loosely correlated
+6.71%
RVMD - MDGL
61%
Loosely correlated
+1.77%
More